Finance, Meetings, and Reporting

Institutional Biosafety Committee (IBC)

Biological and biomedical research plays a critical role in advancing our understanding of health and disease and in developing new, more effective treatments for serious medical conditions. But research involving recombinant DNA, infectious agents, and other hazardous biologics must be conducted with the highest safety standards in mind. Proper containment and biosafety practices are essential to protect researchers, the public, and the environment.

About the IBC

The Institutional Biosafety Committee (IBC) at Henry Ford Health provides oversight for research involving potentially hazardous biological materials, as outlined in the NIH Guidelines. This committee is responsible for evaluating research protocols, ensuring appropriate biosafety containment levels, and promoting safe laboratory practices.

The IBC helps ensure all work aligns with federal regulations and institutional safety standards, fostering a culture of responsible and ethical research.

IBC Committee Roster

• Download IBC Roster - March 2025